Diagnostics : vimarsana.com
Diagnostics
In a story first reported by Nikkei and updated recently by Le Monde, Sony Corp. (NYSE: SNE) and U.S. genome sequencing equipment maker Illumina Inc. (NASDAQ: ILMN) plan to launch a human genome analysis project in October.
The project will involve the study and analysis of genetic material. Read More.
Don t Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Related Keywords
United States, America, Doug Schenkel, Tyler Robertson, Patrick Donnelly, Sean Lavin, Goldman Sachs, Donald Hooker, Foundation Medicine, Amazon Web Services, Nasdaq, Laboratory Corp, Foundation Medicine Inc, Quest Diagnostics Inc, Asuragen Inc, Bio Techne Corp, Walgreens Boots Alliance Inc, Theranos Inc, Sony Corp, Illumina Inc, Health Care, America Holdings, Sony, Sciences Corporation, Techne Corp, Robertson Is Democratizing Diagnosticsthursday, Laptops Tyler Robertson, Analyst Color, Keybanc Capital, Banc Projects, Analyst Donald Hooker, Upside In Exact Sciencestuesday, Analyst Sean, Medicine Set For, Material Upside, Cowen Says In Bullish Initiationthursday, Medicine Inc, Analyst Cowen, Qiagen Has, Strategic Appeal, Analyst Goldman Sachs, Medical Companies, Wall Street Journal, Relationship With Theranos, Illumina Set, Way Doctors Identify, Treat Cancer, ஒன்றுபட்டது மாநிலங்களில், அமெரிக்கா, டக் ஸ்ச்செங்கேழ், டைலர் ராபர்ட்சன்,